A Chinese company is entering the global race to help
Strong activation of anti-bacterial T cells linked to severe COVID-19
A type of anti-bacterial T cells, so-called MAIT cells, are
Research snapshot: COVID-19 and traumatic stress
In the early months of 2020, the novel coronavirus quickly
They survived COVID-19, then faced stigma
From the moment in January when she first heard about
Anti-Influenza Drug Avigan® Tablet Meets Primary Endpoint in Phase III Clinical Trial in Japan for COVID-19 Patients
TOKYO — September 23, 2020 FUJIFILM Toyama Chemical Co., Ltd.
AKI Occurs in 7 Percent of Those Hospitalized With COVID-19
TUESDAY, Sept. 22, 2020 — Acute kidney injury (AKI) occurs
Robot features faster and more comfortable COVID-19 swabbing
A group of clinicians from the National Cancer Centre Singapore
Drug May Reduce Need for Ventilators in COVID-19 Patients
FRIDAY, Sept. 18, 2020 — An inflammation-fighting medicine was associated
Drug shows promise in 1st largely minority COVID-19 study
A drug company said Friday that a medicine it sells
Q&A: COVID-19 pandemic shows signs of affecting alcohol addictions
Less social interaction, increased isolation and more daily life stressors